Condition

Type II Diabetes

ClinicalTrials.gov condition label

Clinical trials65

Recruiting5

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

The GRoceries Aimed at Increasing Nutrition StudyNCT07167004 · 2025-10-14

Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural PatientsNCT06049420 · 2025-02-01

Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes MellitusNCT05028140 · 2024-10-08

Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCTNCT05708859 · 2024-01-02

Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study.NCT05074732 · 2019-12-01

Heart-Kidney-Diabetes Multidisciplinary Care MOdels for CardiovascuLar Health In Patients With Chronic Kidney DiSease and Diabetes: A PragmaTIC Cluster Randomized Controlled Trial (HOLISTIC)NCT07811427 · 2026-12-01

NOT_YET_RECRUITING

Effectiveness of an mHealth Mobile AppNCT06387433 · 2024-03-20

Passive Stretching Versus Electrical Stimulation on Glucose Level, in Elderly With Type II DiabetesNCT06245252 · 2024-02-10

Safety, Pharmacokinetics, and Food Effect of PS1 in SubjectsNCT05176210 · 2023-12-22

The Effects of Raspberry Leaf Tea on Blood Glucose ControlNCT06385626 · 2023-12-18

Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy AdultsNCT05881213 · 2023-06-01

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378NCT05741437 · 2023-04-11

Burger Allen Exercises in Knee OA With Type II DiabetesNCT05878587 · 2023-03-31

Association Between Natural Hypoglycemic Foods and Blood Sugar Level: A Pilot StudyNCT05272839 · 2022-04-01

A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Individual Components in Healthy Chinese SubjectsNCT05108350 · 2021-11-09

A Study to Assess the Effect of Food on HR20033 and Pharmacokinetic After Multiple Dose in Healthy VolunteersNCT05120219 · 2021-10-13

Impact of the Rapid Normalization of Chronic Hyperglycemia and the Practice of Moderate Physical Activity on the "Receptor Activator of Nuclear Factor-kappa B Ligand / Osteoprotégérine (RANKL / OPG) System in Patients Living With Type II DiabetesNCT04893135 · 2021-10-11

Dietary Approaches to Stop Hypertension for DiabetesNCT04286555 · 2021-06-02

A Study to Investigate the PK and Safety of CKD-393NCT04768673 · 2021-03-26

Mass Balance and Biotransformation of [14C]HSK7653 in HumanNCT04540016 · 2020-11-15

Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II DiabetesNCT06224803 · 2020-08-26

Educational Intervention Targeting Statin Therapy and Compliance in Diabetic PatientsNCT04499846 · 2020-06-11

INTEGRATE-D: A Pilot Test to Support Integration of Medical and Psychosocial Care for People With Type II DiabetesNCT04461405 · 2020-03-01

SOKARY Mobile Application With Type II DiabetesNCT04843592 · 2019-08-30

Peer Support Dyads in ChurchesNCT03463941 · 2019-01-05

Supplementation of Brown Seaweed on Insulin Resistance of NAFLD Patients With Pre- or Type 2-DiabetesNCT04715776 · 2018-12-10

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy AdultsNCT03646799 · 2018-08-30

Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance ImagingNCT03498001 · 2018-04-16

Determination of the Optimum Cut-off Value of Type 2 Diabetes Diagnosis Among Chinese Population(SENSIBLE STUDY II)NCT03024788 · 2017-01-01

Role of Gastrointestinal Microbes on Digestion of Resistant Starch and Tryptophan Availability to HumansNCT02974699 · 2017-01-01

Providing Preventive Periodontal Treatment to Hospitalized Patients With DiabetesNCT02914743 · 2016-11-01

Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II DiabeticsNCT01001962 · 2016-01-01

Salivary Transcriptome Biomarkers for Early Diabetes DetectionNCT02673762 · 2016-01-01

Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot StudyNCT02471794 · 2015-12-01

Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II DiabetesNCT02586129 · 2015-11-04

Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)NCT02947620 · 2015-08-01

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or InsulinNCT02429258 · 2015-05-01

Mobile Unit Screening of Pathologies Associated With Chronic Diseases - FeasibilityNCT02214056 · 2015-02-01

Clinical Trial for PB-119 in Healthy Subjects (Phase I)NCT02084251 · 2014-02-01

Januvia (Sitagliptin) in Healing Chronic Diabetic Foot UlcersNCT02015910 · 2014-01-01

Initial Clinical Evaluation of an Endoscopic Therapy for Type 2 DiabetesNCT01927562 · 2013-07-13

Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice ExperimentNCT02637622 · 2013-07-01

Measuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst ScalingNCT02637609 · 2013-07-01

Fatty Liver Study in Patients With Type II DiabetesNCT02365233 · 2013-05-01

Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 DiabetesNCT01804777 · 2013-03-01

Using EEG Operant Conditioning to Improve Trait Self-Control and Promote Healthy BehaviorNCT01801254 · 2013-02-01

Type II Diabetes Influence on Left Ventricular Remodeling and Outcomes in Patients Undergoing Aortic Valve Replacement Surgery.NCT01862237 · 2012-12-01

Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and TitrationNCT01698528 · 2012-10-01

The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic PatientsNCT04569214 · 2012-09-01

The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral NeuropathyNCT02127762 · 2012-09-01

Activator and Type II DiabeticsNCT01782092 · 2012-08-01

Diabetes Mellitus Community Based Screening in Minority PopulationsNCT01591525 · 2012-06-01

Periodontal Treatment Response in Type II Diabetic PatientsNCT01881074 · 2012-06-01

Effects of Purple Vegetables on Cardiovascular Disease (CVD) Risk FactorsNCT01564498 · 2012-04-01

Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763NCT01619332 · 2012-03-01

Intensive Discharge Intervention in DiabetesNCT02122926 · 2011-12-01

Biospecimens for Identification of Diseases of the Pancreas.NCT01392027 · 2011-04-01

The Effect of Gastric Bypass Surgery on DiabetesNCT01330251 · 2011-01-01

Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and ObesityNCT00985114 · 2009-10-01

Fracture Risk With ThiazolidinedionesNCT01055223 · 2009-05-01

Common interventions

Leading sponsors

Chong Kun Dang Pharmaceutical4 AstraZeneca3 Duke University2 Johns Hopkins Bloomberg School of Public Health2 Shandong Suncadia Medicine Co., Ltd.2 Antenna Foundation1 Aristotle University Of Thessaloniki1 Baim Institute for Clinical Research1 Boston Therapeutics1 Brigham and Women's Hospital1 Centre Hospitalier Sud Francilien1 Centre Hospitalier Universitaire de Nīmes1 Centre Hospitalier Universitaire Dijon1 Daewoong Pharmaceutical Co. LTD.1 Dow University of Health Sciences1

Trial status mix

COMPLETED39

UNKNOWN16

RECRUITING5

TERMINATED3

NOT_YET_RECRUITING1

WITHDRAWN1

Phase mix

NA24

PHASE114

PHASE46

PHASE23

PHASE33

EARLY_PHASE12

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.